首页> 美国卫生研究院文献>The British Journal of Ophthalmology >A randomised prospective study comparing trabeculectomy augmented with antimetabolites with a viscocanalostomy technique for the management of open angle glaucoma uncontrolled by medical therapy
【2h】

A randomised prospective study comparing trabeculectomy augmented with antimetabolites with a viscocanalostomy technique for the management of open angle glaucoma uncontrolled by medical therapy

机译:一项随机前瞻性研究比较了小梁切除术加抗代谢物与粘膜吻合口吻合术治疗药物治疗无法控制的开角型青光眼的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aims: To compare trabeculectomy with viscocanalostomy for the control of intraocular pressure (IOP) in open angle glaucoma (OAG) uncontrolled by medical therapy.>Methods: 48 patients (50 eyes) with uncontrolled OAG were randomised to either trabeculectomy (25 eyes) or a viscocanalostomy technique (25 eyes). Preoperatively, eyes were graded in terms of risk factors for drainage failure. Those undergoing trabeculectomy were given intraoperative antimetabolites (5-fluorouracil 25 mg/ml (5-FU), mitomycin C (MMC) 0.2 mg/ml and 0.4 mg/ml) according to a standard protocol. Antimetabolites were not used intraoperatively in eyes undergoing viscocanalostomy, but they were randomised to the use of viscoelastic (Healonid GV) for intraoperative intracanalicular injection.>Results: There were no significant differences between the groups in age, sex, type of OAG, preoperative medications, risk factors for drainage failure, and preoperative IOP. Mean follow up was 19 months (range 6–24 months). It was 12 months or longer in all eyes, except one lost to follow up at 6 months. At 12 months, complete success (IOP <21 mm Hg without antiglaucoma medications) was seen in all eyes undergoing trabeculectomy (100%), but in only 64% of eyes undergoing viscocanalostomy (p<0.001). The mean IOP was lower at 12 months (p<0.001) with trabeculectomy and the number of eyes with IOPs of 15 mm Hg or less was greater (p<0.05). The mean IOP at 12 months was lower in eyes that had undergone viscocanalostomy using intraoperative intracanalicular Healonid GV injection compared to those where only balanced saline solution had been used (p<0.01). However, in terms of complete success there was no difference between the viscocanalostomy groups (p<0.1). With the exception of measurements at 1 week, visual recovery (logMAR acuity) was similar and laser flare and cell values showed little differences between the groups. Corneal topography and keratometry at 12 months were little different from preoperative values. Postoperative interventions (subconjunctival 5-FU and needling procedures) were similar between the groups. Transient complications such as early bleb leak and hyphaema were more common in the trabeculectomy group (p<0.05). Postoperative cataract formation was more common after trabeculectomy (p<0.05).>Conclusions: IOP control appears to be better with trabeculectomy. Viscocanalostomy is associated with fewer postoperative complications, although significant complications permanently impairing vision did not occur with either technique.
机译:>目标:比较小梁切除术和粘膜吻合口吻合术在药物治疗无法控制的开角型青光眼(OAG)中控制眼压(IOP)的作用。>方法::48例(50眼) OAG不受控制的患者随机分为小梁切除术(25眼)或粘膜吻合术(25眼)。术前,根据引流失败的危险因素对眼睛进行分级。根据标准方案,对接受小梁切除术的患者术中给予抗代谢物(5-氟尿嘧啶25 mg / ml(5-FU),丝裂霉素C(MMC)0.2 mg / ml和0.4 mg / ml)。术中未使用抗代谢物进行粘膜吻合术,但被随机分配到粘膜内(Healonid GV)术中进行小管内注射。>结果:两组之间的年龄,性别, OAG的类型,术前用药,引流失败的危险因素和术前IOP。平均随访时间为19个月(6-24个月)。所有人的眼睛都在12个月或更长时间,除了一个在6个月时失去随访的人。在第12个月时,所有接受小梁切除术的眼睛均获得了完全成功(无抗青光眼药物的IOP <21毫米汞柱)(100%),但只有64%的患者接受了黏膜吻合术(p <0.001)。小梁切除术在12个月时的平均IOP较低(p <0.001),而IOP在15 mm Hg或以下的眼数则更大(p <0.05)。与仅使用平衡盐水溶液的患者相比,术中使用小管内Healidid GV注射进行粘膜吻合术的眼睛在12个月时的平均IOP较低(p <0.01)。但是,就完全成功而言,粘膜吻合口吻合术组之间没有差异(p <0.1)。除了第1周的测量值外,两组之间的视觉恢复(logMAR视力)相似,激光耀斑和细胞值几乎没有差异。 12个月时的角膜地形图和角膜曲率与术前值几乎没有差异。两组之间的术后干预措施(结膜下5-FU和针刺程序)相似。在小梁切除术组中,早期并发症,如早期气泡漏出和菌丝增多,更为常见(p <0.05)。小梁切除术后白内障的形成更为普遍(p <0.05)。>结论:小梁切除术对眼压的控制似乎更好。尽管两种技术都没有发生永久性损害视力的重大并发症,但粘膜吻合术术后并发症较少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号